A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

The company, which was founded in 2015 to develop therapies for blood cancers, pointed to “currently available clinical data ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

R&D Expenses: $118.6 million for Q1 2025, including $7 million of noncash stock-based compensation. SG&A Expenses: $23.9 ...

Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite ...

Adjusted EBITDA improved significantly to $-16.2 million compared to $-43.9 million in Q1 2024, representing a $27.8 million ...

The Technology Enterprises Channel aims to assist innovative firms raise funds, as outlined in Paul Chan’s budget speech in ...

Krystal Biotech KRYS reported first-quarter 2025 earnings per share (EPS) of $1.20, which missed the Zacks Consensus Estimate ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

Boeing stock is impacted by trade tensions between the US and China. Read why, long term, the outlook is positive for the ...

Portage Biotech is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider ...

The brokerage currently has a $4.00 target price on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 target price on shares of Unity Biotechnology in a research ...